Oncolytic Virus Platform

Oncolytic viruses (OVs) are emerging as a promising therapeutic approach for treating cancer. OVs are capable of both tumor-specific cell lysis and immune stimulation and can be optimized for enhanced tumor selectivity.  WuXi AppTec offers a comprehensive platform of OV-related services, including virus engineering and validation, immune profiling and lysis assays, tumor cell selectivity assays, in vivo efficacy and safety studies, as well as bio-distribution and viral shedding assays.

Check out our panel of OV services


Oncolytic Virus Platform


← Return to Resources

Related Content

The Son of Sevenless (SOS) protein is a guanine nucleotide exchange factor that acts as a key activator for KRAS...


The RAS family of small GTPases are among the most frequently mutated oncogenes in human cancer. Previously viewed as undruggable,...

← View all Biochemical Assays Resources
× peptide, amino acid

Contact An Expert Today!